JWH-133
From Wikipedia, the free encyclopedia
| JWH-133 | |
|---|---|
| Chemical name | 3-(1,1-Dimethylbutyl)-1-deoxy- Δ8-tetrahydrocannabinol |
| Chemical formula | C22H32O |
| Molecular mass | 312.49 |
| Solubility |
DMSO: <0.16 mg/mL |
|
|
|
JWH-133 is a potent selective CB2 receptor agonist.
JWH-133, along side WIN 55,212-2 and HU-210, is implicated in preventing the inflammation caused by Amyloid beta proteins involved in Alzheimer's Disease, in addition to preventing cognitive impairment and loss of neuronal markers. This antiinflmatory action is induced through the agonization of cannabinoid receptors which prevents microglial activation that elicits the inflammation. Additionally, cannabinoids completely abolish neurotoxicity related to microglia activation in rat models.
[edit] External links
- JNeurosci.org Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation
Anandamide • 2-AG • CBD • CBDV • CBN • CBV • CP 55,940 • HU-210 • Levonantradol • JWH-133 • Nabilone • THC • THCV • URB597 • URB754 • WIN 55,212-2 • Rimonabant • AM251 • THC-O-phosphate • Parahexyl
